Mechanism

Ataxin-2 (ATXN2) mRNA

Assets acting on this target.

Class
Antisense oligonucleotide (ASO) targeting ATXN2
Notes
verified in session 2026-08-25 (owner-delegated review); source: https://clinicaltrials.gov/study/NCT04494256

← all mechanisms